January 9, 2024
David Y. Hwang, MD, professor of neurology and division chief of neurocritical care, is co-principal investigator along with colleagues at Duke for a new eastern North Carolina and southern Virginia stroke clinical trial coordinating center.
November 7, 2023
UNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.
October 18, 2023
James F. Howard, MD, Distinguished Professor of Neuromuscular Disease, Professor of Neurology, Medicine and Allied Health at the UNC School of Medicine, was the lead investigator of the clinical trial.
August 21, 2023
A $100,000 grant from the Neurocritical Care Foundation has been awarded to David Y. Hwang MD, division chief of neurocritical care in the Department of Neurology at the UNC School of Medicine, and colleagues to research an intervention to support family caregivers of patients surviving ICU admission for coma.
August 21, 2023
Miriam Sklerov, MD, of the UNC Neurology Movement Disorders Center, recently won a National Institutes of Mental Health K23 award for her project, "Investigation of non-invasive brain stimulation for the treatment of apathy."
August 21, 2023
UNC Neurology researcher Ian Shih has received a $2.4 million NIH grant to improve functional brain imaging techniques.
August 16, 2023
A $100,000 grant from the Neurocritical Care Foundation has been awarded to David Y. Hwang MD, FAAN, FCCM, FNCS, division chief of neurocritical care in the Department of Neurology at the UNC School of Medicine, and colleagues to research an intervention to support family caregivers of patients surviving ICU admission for coma.
June 22, 2023
Published in The Lancet Neurology, a study led by James Howard, MD, professor of neurology at the UNC School of Medicine, showed how an RNA CAR-T therapy developed by Cartesian Therapeutics can dramatically improve symptoms in patients with myasthenia gravis, an autoimmune disorder.
April 13, 2023
James Howard, MD, professor of neurology at the UNC School of Medicine, was the principal investigator of the RAISE clinical trial of zilucoplan, one of two drugs under regulatory review to treat myasthenia gravis.
April 7, 2023
Dominique Higgins, MD, PhD, led research into how a specialized diet can induce a new type of programmed cell death to help kill brain tumor cells.
March 10, 2023
Gregory Scherrer, PharmD, PhD, associate professor of cell biology and physiology and member of the UNC Neuroscience Center, received a Director’s Award for Excellence in Research, and Sarah Linnstaedt, PhD, associate professor of anesthesiology, earned an honorable mention for the Director’s Trailblazer award.
February 15, 2023
Researchers from the UNC School of Medicine, led by Ian Shih, PhD, Professor and Vice Chair of Neurology and Associate Director of the Biomedical Research Imaging Center, revealed the role of the insular cortex in controlling the Default Mode Brain Network.